Cellectis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Cellectis and buy or sell other stocks, ETFs, and their options commission-free!

About CLLS

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. 

CEO
André Choulika
CEOAndré Choulika
Employees
222
Employees222
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
1999
Founded1999
Employees
222
Employees222

CLLS Key Statistics

Market cap
191.51M
Market cap191.51M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
63.47K
Average volume63.47K
High today
$2.68
High today$2.68
Low today
$2.57
Low today$2.57
Open price
$2.63
Open price$2.63
Volume
35.02K
Volume35.02K
52 Week high
$3.24
52 Week high$3.24
52 Week low
$1.10
52 Week low$1.10

Analyst ratings

75%

of 8 ratings
Buy
75%
Hold
25%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.